Obesity trials in China

In China 247 Also abroad 2008

210 of 247 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 1Not yet taking people in China
Study of IPG1094 Tablets in Chinese Healthy Adults and Obese Adults
Where
Hangzhou
Age
18 years to 50 years
People
72
Run by
Nanjing Immunophage Biotech Co., Ltd
See details and how to joinNCT07935291
Phase 1Not yet taking people in China
A Phase I Study to Evaluate the Food Effect on Ecnoglutide Tablet
Where
Hangzhou
Age
18 years to 50 years
People
72
Run by
Hangzhou Sciwind Biosciences Co., Ltd.
See details and how to joinNCT07936058
No phaseTaking people
Nasopharyngeal Airway Combined With Nasal High-flow Oxygen Therapy During Painless Gastroscopy in Obesity Patients
Where
Nanjing
Age
18 years and over
People
364
Run by
Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT06966934
Phase 2Taking people
Effect of Retatrutide Versus Placebo in Participants Who Have Obesity or Are Overweight
Where
Shenzhen
Age
18 years to 75 years
People
300
Run by
Hudson Biotech
See details and how to joinNCT07467447
Phase 3Taking people
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)
Where
Shenzhen
Age
18 years and over
People
2,539
Run by
Hudson Biotech
See details and how to joinNCT07481747
Phase 3Taking people
Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) Therapy
Where
Beijing
Age
18 years and over
People
140
Run by
Gan & Lee Pharmaceuticals.
See details and how to joinNCT07493057
Phase 3Taking people
Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Receiving Positive Airway Pressure (PAP) Therapy
Where
Beijing
Age
18 years and over
People
140
Run by
Gan & Lee Pharmaceuticals.
See details and how to joinNCT07501832
No phaseTaking people
ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management
Where
Fuzhou, Guiyang, Hangzhou, Luzhou, Nanchang, Shanghai, Suzhou, Taiyuan, Wenzhou, Wuhan, Xiamen, Zunyi
Age
18 years and over
People
420
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07517042
Phase 3Not yet taking people in China
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Where
Chengdu, Luoyang, Nanjing, Shanghai
Age
18 years and over
People
600 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07850063 · EU 2026-527091-88-00
No phaseTaking people
Fecal Microbiota Transplantation for Obese Women With Polyendocrine Metabolic Ovarian Syndrome
Where
Shanghai
Age
20 years to 40 years
People
411
Run by
Shanghai Changzheng Hospital
See details and how to joinNCT07746635
Phase 2Not yet taking people in China
A Study to Evaluate the Safety and Efficacy of Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
Where
Luoyang
Age
18 years to 65 years
People
180
Run by
Hangzhou Sciwind Biosciences Co., Ltd.
See details and how to joinNCT07929298
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Beijing, Changchun, Hefei, Herbin, Huizhou, Jinan, Langfang, Luoyang, Nanjing, Pingxiang, Shanghai, Suzhou, Xianyang, Zhenjiang
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Beijing, Cangzhou, Changchun, Hefei, Herbin, Huizhou, Jinan, Kaifeng, Langfang, Luoyang, Nanjing, Ningbo, Pingxiang, Shanghai, Siping, Suzhou, Wuxi, Xi'an, Xianyang, Xuzhou, Yueyang, Zhenjiang
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
Where
Baotou, Beijing, Changde, Changsha, Changzhou, Chengdu, Hefei, Huangshi, Jincheng, Jinzhou Shi, Langfang, Luoyang, Meihekou, Nanjing, Nanyang, Shanghai, Shantou, Shenyang, Shijiazhuang, Wuhan, Wuhu, Xianyang, Xuzhou, Yan’an, Yueyang, Zhumadian, Zibo
Age
18 years and over
People
351 worldwide
Run by
AstraZeneca
See details and how to joinNCT07775404
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Beijing, Changchun, Chengdu, Guangzhou, Huzhou, Nanjing, Ningbo
Age
18 years and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
No phaseTaking people
Explore the Weight Loss Effect of Amway "BODY TRIMMER"
Where
Shanghai
Age
30 years to 65 years
People
110
Run by
Amway (China) R&D Center
See details and how to joinNCT07924956
No phaseTaking people
Determination of ED90 of Remimazolam Besylate Combined With Alfentanil for Gastroscopy Sedation in Obese Patients
Where
Jinan
Age
18 years to 65 years
People
120
Run by
Jianbo Wu
See details and how to joinNCT07925684
Phase 3Taking people
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or Obesity
Where
Beijing, Hefei, Huizhou, Nanchang, Nanjing, Zhengzhou
Age
18 years and over
People
432
Run by
Pfizer
See details and how to joinNCT07874633
Phase 3Not yet taking people in China
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Where
Beijing, Bozhou, Cangzhou, Changzhou, Chongqing, Daqing, Ganzhou, Guangzhou, Jiaxing, Jinan, Liuzhou, Luoyang, Luzhou, Sanya, Shanghai, Shenyang, Shiyan, Suzhou, Wuhan, Xi'an, Xuancheng, Yuncheng, Zhengzhou
Age
18 years and over
People
330 worldwide
Run by
AstraZeneca
See details and how to joinNCT07922330
Phase 1Taking people
A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects
Where
Hefei
Age
18 years to 65 years
People
126
Run by
Sunshine Lake Pharma Co., Ltd.
See details and how to joinNCT07102251
Phase 3Taking people
A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
Where
Beijing, Changchun, Hefei, Herbin, Huai'an, Huzhou, Jinan, Langfang, Luoyang, Nanjing, Ningbo, Shanghai, Shenyang, Shijiazhuang, Xianyang, Zhengzhou, Zibo
Age
18 years and over
People
300
Run by
Hoffmann-La Roche
See details and how to joinNCT07670416
Phase 3Taking people
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
Where
Beijing, Changchun, Changzhou, Chongqing, Hangzhou, Harbin, Hefei, Hengshui, Huizhou, Huzhou, Jinan, Luoyang, Nanchang, Nanjing, Nantong, Ningbo, Pingxiang, Shanghai, Shijiazhuang, Shiyan, Tianjin, Wuhan, Xi'an, Zhengzhou, Zhenjiang
Age
18 years and over
People
300
Run by
Pfizer
See details and how to joinNCT07792954
Phase 3Taking people
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Where
Chengdu, Hefei, Jinan, Luoyang Shi, Nanjing, Ningbo, Qinhuangdao Shi, Tianjin
Age
18 years and over
People
2,001 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00
Phase 1Taking people
Study of UBT37034 Injection
Where
Changsha
Age
18 years to 55 years
People
40
Run by
The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07873645
No phaseNot yet taking people in China
Gut Microbiota-Based Clinical Study of Akkermansia Supplementation for Overweight and Obesity
Where
Nanchang
Age
18 years to 60 years
People
150
Run by
Second Affiliated Hospital of Nanchang University
See details and how to joinNCT07898267